{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-004232","form_type":"8-K","ticker":"SEER","cik":"0001726445","company_name":"Seer, Inc.","filed_at":"2022-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.957094+00:00","generated_at":"2026-06-27T03:44:46.570032+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Seer Q4 2021 rev $3.1M, FY rev $6.6M; guides FY2022 rev $14-16M","bullets":["Q4 revenue $3.1M (up from $336K YoY); net loss $19.7M vs $12.9M.","Full-year 2021 revenue $6.6M vs $656K; net loss $71.2M vs $32.8M.","Gross margin 47% in Q4, 52% for full year; cash+investments $493.3M.","Shipped 17 instruments through year-end 2021; broad commercial release of Proteograph commenced.","2022 revenue guidance $14-16M; expects to increase investments in commercial, ops, and R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-004232","json":"https://secwatch.observer/filing/0001628280-22-004232.json","markdown":"https://secwatch.observer/filing/0001628280-22-004232.md","text":"https://secwatch.observer/filing/0001628280-22-004232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726445/000162828022004232/0001628280-22-004232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726445/000162828022004232/seer-20220228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:44:46.570032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}